Company / Operating Cash Flow per Share
Monte Rosa Therapeutics, Inc. Operating Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.57
FY2024
5-year range
-$15.20 / $0.57
FY2020-FY2024
Trend
+166.7%
vs FY2023
Sector context
#64 of 212
Health Care
What the data says
At $0.57, Monte Rosa Therapeutics, Inc.'s operating cash flow per share ranks #64 of 212 in the Health Care sector. Operating Cash Flow per Share has increased for 4 consecutive years, from $-15.20 in FY2020 to $0.57 in FY2024.
Based on SEC 10-K filings.
0.57 in FY2024.
Improved from $-1.96 to $0.57 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#64 of 212 in Health CareTop 30% of 212This company $0.57 Sector average -$14.72
▼
+103.9% above sector average
Key checks
Key Insights
- Monte Rosa Therapeutics, Inc.'s operating cash flow per share has grown for 4 consecutive years.
- In FY2024, operating cash flow per share increased 166.7% year-over-year.
- Ranks #64 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.57 | +166.7% |
| FY2023 | -$0.85 | +56.5% |
| FY2022 | -$1.96 | +17.5% |
| FY2021 | -$2.37 | +84.4% |
| FY2020 | -$15.20 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026